Filing Details
- Accession Number:
- 0001209191-20-009365
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-13 17:36:53
- Reporting Period:
- 2020-02-11
- Accepted Time:
- 2020-02-13 17:36:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1775295 | Christine Chung | C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158 | Svp, China Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-11 | 5,625 | $25.40 | 138,269 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-11 | 5,625 | $44.48 | 132,644 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-02-12 | 5,625 | $25.40 | 138,269 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-12 | 5,025 | $45.94 | 133,244 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-12 | 600 | $46.28 | 132,644 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-11 | 5,625 | $0.00 | 5,625 | $25.40 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-02-12 | 5,625 | $0.00 | 5,625 | $25.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 48,089 | 2027-03-08 | No | 4 | M | Direct | |
| 42,464 | 2027-03-08 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- The shares were sold at prices ranging from $43.77 to $44.71. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $45.22 to $46.21. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $46.22 to $46.435. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Twenty-five percent of the shares subject to the option vested on March 1, 2018, and the remainder vested in equal amounts quarterly thereafter for the following three years.
Billionaire Hedge Funds
